Autonomix Medical enters $2.1M ATM equity facility; reverse split share dispute

Autonomix Medical, Inc.

Entered ATM sales agreement with Ladenburg Thalmann for up to $2.1M of common stock; 3.0% agent commission.
Proceeds from ATM to be used for working capital and general corporate purposes.
October 2024 1-for-20 reverse split reduced shares from ~23M to ~1.15M; authorized shares remain 500M.
DTCC requested 271,846 shares for fractional rounding; company disputes and has not issued; potential liability.
Retrospective restatement of per-share data in 10-K to reflect reverse split; no new financial results.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.